Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)

Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Sileni, Vanna Chiarion; Dutriaux, Caroline; Yamazaki, Naoya; Loquai, Carmen; Queirolo, Paola; de Willem, Groot Jan; Sellier, Abir Tadmouri; Suissa, Jeanne; Murris, Juliette; Gollerkeri, Ashwin; Robert, Caroline; Flaherty, Keith T.

Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)

Autor(en):

Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Sileni, Vanna Chiarion; Dutriaux, Caroline; Yamazaki, Naoya; Loquai, Carmen; Queirolo, Paola; de Willem, Groot Jan; Sellier, Abir Tadmouri; Suissa, Jeanne; Murris, Juliette; Gollerkeri, Ashwin; Robert, Caroline; Flaherty, Keith T.

Tübinger Autor(en):

Garbe, Claus

Erschienen in:

European Journal of Cancer (2021), Bd. 152, S. 116-128

Verlagsangabe:

Elsevier Sci Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.ejca.2021.04.028

ISSN:

1879-0852